Download now
← Case studies
2022-03-01Continuous complianceDataRegulations

Biopharma Company Saves $500k by Qualifying Salesforce

Case study on Biopharma Company Saves $500k by Qualifying Salesforce.

USDM delivered restructured data systems while ensuring continuous compliance and reduced risk

Learn how USDM saved a biopharma company with $30B in annual revenue more than $500k in licensing fees by implementing Salesforce GxP capabilities, which created baseline and automated testing as well as risk-based validation.

The Situation
  • Leading biopharma company with more than $30B in annual revenue
  • Dozens of platforms used by more than 8,000 employees
  • Entrenched belief that Salesforce could not be used in a qualified way
  • Minimal cloud adoption for GxP use cases
  • No compliance framework for assessing and maintaining a validated state for cloud based applications
The Solution
  • USDM established a robust cloud compliance framework to manage risks
  • USDM implemented Cloud AssuranceTM for Salesforce to create baseline and automated testing to maintain a continuously compliant state
  • USDM then established risk-based validation commensurate with intended use of system, regulatory rigor, technical complexity, business risk, and data integrity risk
  • USDM's VAP provided baseline qualification/validation deliverables
  • An annual Salesforce audit was included as part of the subscription
  • Validation augmented by SQA (automated) testing and Functional Risk Assessments Validation vs. Qualification Qualified underlying common capabilities (features and functionality)
  • Established simplified end-use validation based on verifying configurations of common capabilities; user acceptance/PQs; and extensive validation only for unique capabilities

The Results

  • $500k+SAVED THE FIRST YEAR in license costs​
  • Continuous Cloud Compliance​
  • Optimized Salesforce for GxP functionality

Learn more about USDM's Salesforce GxP digital transformation services.

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

  • Workflow inventory and risk classification
  • Business value and readiness scoring
  • FDA CSA + EU AI Act + ISO 42001 gap analysis
  • Prioritized 90-day roadmap by impact, risk, and effort

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.